Elutia Inc (ELUT)

08:56 AM

Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Bitget

08:56 AM

08:22 AM

Elutia markets another product for sale as it pivots to breast reconstruction infection prevention - The Business Journals

08:22 AM

08:00 AM

Elutia grants 460,000 stock options to 3 new hires at $1.09 - Stock Titan

08:00 AM

07:29 AM

Elutia (ELUT) Q4 2025 Earnings Call Transcript - AOL.com

07:29 AM

Mar 12, 2026

Elutia Q4 2025 slides: $88M sale funds pivot to breast reconstruction - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Elutia Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-03-12 - Seeking Alpha

Mar 12, 2026

Mar 12, 2026

Elutia Reports Strong 2025 Financial Results, Advances NXT-41x for Breast Cancer Surgery, and Closes $88M BioEnvelope Sale to Boston Scientific - Minichart

Mar 12, 2026

Mar 12, 2026

Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Moves Amid ... By GuruFocus - Investing.com Canada

Mar 12, 2026

Mar 11, 2026

Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Grow - GuruFocus

Mar 11, 2026

Mar 11, 2026

Elutia Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 11, 2026

Mar 11, 2026

Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process - Bitget

Mar 11, 2026

Mar 11, 2026

Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady By Investing.com - Investing.com Australia

Mar 11, 2026

Mar 11, 2026

Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady - Investing.com India

Mar 11, 2026

Mar 11, 2026

Elutia earnings beat by $1.60, revenue topped estimates - Investing.com Canada

Mar 11, 2026

Mar 11, 2026

Elutia reports $3.3M Q4 revenue, $70.8M net income on BioEnvelope sale; $44.4M year-end cash - TradingView

Mar 11, 2026

Mar 11, 2026

ELUTIA ($ELUT) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative

Mar 11, 2026

Mar 11, 2026

Elutia Q4 revenue rises on higher cardiovascular product sales - TradingView

Mar 11, 2026

Mar 10, 2026

Elutia Inc. Adopts 2026 Inducement Award Plan and Files Form 8-K Disclosure - Minichart

Mar 10, 2026

Mar 10, 2026

Exploring Elutia's Earnings Expectations - Benzinga

Mar 10, 2026

Mar 10, 2026

Elutia Inc (ELUT) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus

Mar 10, 2026

Mar 09, 2026

Elutia Adopts 2026 Inducement Equity Award Plan - TipRanks

Mar 09, 2026

Mar 09, 2026

Elutia Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView

Mar 09, 2026

Mar 06, 2026

Risks Report: Is Elutia Inc subject to activist investor interestMarket Rally & Accurate Entry/Exit Alerts - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status - The Globe and Mail

Mar 06, 2026

Mar 05, 2026

Elutia (ELUT) Expected to Announce Earnings on Wednesday - MarketBeat

Mar 05, 2026

Mar 04, 2026

Elutia regains compliance with Nasdaq listing requirements - Investing.com Australia

Mar 04, 2026

Mar 04, 2026

Elutia regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada

Mar 04, 2026

Mar 04, 2026

Elutia regains Nasdaq compliance after meeting minimum bid price and MVLS - TradingView

Mar 04, 2026

Mar 04, 2026

Elutia Regains Compliance with Nasdaq Listing Requirements - Bitget

Mar 04, 2026

Mar 04, 2026

Elutia (NASDAQ: ELUT) regains full Nasdaq listing compliance after bid price, value breach - Stock Titan

Mar 04, 2026

Mar 03, 2026

Elutia names Pete Ligotti chief commercial officer - Investing.com

Mar 03, 2026

Mar 02, 2026

Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market - Bitget

Mar 02, 2026

Mar 02, 2026

Elutia Selects Pete Ligotti as CCO to Lead the Commercial - GlobeNewswire

Mar 02, 2026

Mar 02, 2026

New Elutia CCO targets 15–20% infection rates in breast reconstruction - Stock Titan

Mar 02, 2026

Feb 27, 2026

ELUT Should I Buy - Intellectia AI

Feb 27, 2026

Feb 25, 2026

Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026 - Bitget

Feb 25, 2026

Feb 25, 2026

ELUT SEC FilingsElutia Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 25, 2026

Feb 24, 2026

ELUT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Feb 23, 2026

Interview with the President and CEO: Elutia Inc. (NASDAQ:ELUT) - The Wall Street Transcript

Feb 23, 2026

Feb 20, 2026

Short Squeeze: What is the PEG ratio of Brookdale Senior Living IncStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Feb 20, 2026

Feb 19, 2026

Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification - HRTech Series

Feb 19, 2026

Feb 18, 2026

Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™ - The Manila Times

Feb 18, 2026

Feb 17, 2026

Targets Report: What is the Moat Score of Elutia IncJuly 2025 Earnings & Technical Confirmation Trade Alerts - baoquankhu1.vn

Feb 17, 2026

Feb 17, 2026

Alyeska discloses 3.18% Elutia (ELUT) stake in amended 13G - Stock Titan

Feb 17, 2026

Feb 15, 2026

Elutia Inc. (NASDAQ:ELUT) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st

Feb 15, 2026

Feb 13, 2026

Short Covering: Is Elutia Inc benefiting from innovation trendsJuly 2025 Big Picture & Community Verified Trade Signals - baoquankhu1.vn

Feb 13, 2026

Feb 13, 2026

What is Elutia Inc. s debt to equity ratioJuly 2025 Closing Moves & Safe Capital Growth Plans - mfd.ru

Feb 13, 2026

Feb 13, 2026

Knollwood discloses 6.3% Elutia Inc (NASDAQ: ELUT) stake - Stock Titan

Feb 13, 2026